Nasdaq
$2.41▲ 1.47%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $101.0MShares out 41.9M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
6- 9.29After-hours26.09.30 05:198-KKey event#●●●
Apyx Medical Corp
Apyx Medical announced results from a prospective clinical study demonstrating the efficacy of its Renuvion helium plasma technology in improving skin quality. At the 180-day mark, 100% of participants reported aesthetic improvements, supported by histological evidence of increased elastin density and reduced inflammation in treated tissue.…more
$2.41+1.47%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.7After-hours26.08.08 05:008-KKey event
Apyx Medical Corp
Apyx Medical Corp은 2026년 8월 6일 개최된 연례 주주총회에서 400만 주 규모의 '2026 주식 인센티브 플랜'을 승인했습니다. 또한 이번 총회를 통해 5명의 이사 선임, 외부 회계법인 RSM US LLP 선임, 임원 보상안에 대한 주주 승인 절차를 완료했습니다.…more
$2.41+1.47%vs prev closeView filingShare - 8.6After-hours26.08.07 06:0110-QEarnings
Apyx Medical Corp
Apyx Medical Corp의 2026년 2분기 매출은 1,388만 달러로 전년 동기 1,137만 달러 대비 증가했으나, 영업손실은 180만 달러를 기록했습니다. 2026년 6월 30일 기준 현금 및 현금성 자산은 2,761만 달러이며, 발행 주식 수는 4,211만 6,330주입니다.…more
$2.41+1.47%vs prev closeView filingShare
5 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoPre-market26.10.21 21:00#●●●
Apyx Medical to Participate in Upcoming Investor Conferences
Apyx Medical Corporation announced that its management will participate in upcoming investor conferences hosted by UBS and Canaccord Genuity in November. The company will conduct fireside chats and hold one-on-one meetings with investors during these events.…more
$2.41+1.47%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.29Pre-market26.09.29 21:00
●●●●●●●● ●●●●● ●●●●●●
Apyx Medical announced new clinical study results showing that its Renuvion technology improves skin elasticity and reduces inflammation at the tissue level. While the study provides scientific evidence for the product's efficacy, it does not represent an immediate financial catalyst, warranting a neutral outlook.…more
$2.41+1.47%vs prev close - 8.6After-hours26.08.07 05:05
●●●●●●●● ●●●●● ●●●●●●
에이픽스 메디컬은 수술용 미용 부문의 성장에 힘입어 2분기 매출이 전년 동기 대비 22% 증가하며 적자 폭을 줄였습니다. 회사는 AYON 플랫폼의 시장 수요 확대와 FDA 승인 효과를 바탕으로 연간 매출 목표를 유지했습니다.…more
$2.41+1.47%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report